UDQ [2015] NSWCATGD 12

UDQ [2015] NSWCATGD 12

The Tribunal found Mr UDQ incapable of giving consent due to his advanced dementia, accepted evidence that Cyproterone was the only appropriate treatment for his behavioural and prostatic symptoms, confirmed the treatment was manifestly in his best interests, and thus granted consent to the administration of Cyproterone for two years.

Jurisdiction
Australia
Judgment Date
23 June 2015
Procedural Posture
Guardianship Application / Decision on Application for Consent to Special Medical Treatment
Outcome
Consent to administration of Cyproterone (Androcur) up to 100 mg daily for two years granted
Legal Topics
['special Medical Treatment' 'consent for Medical Treatment' 'capacity to Consent']

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 2 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Procedural Posture

Guardianship Application / Decision on Application for Consent to Special Medical Treatment

  1. 1 ['Whether Mr UDQ is incapable of giving informed consent to special medical treatment' "Whether the proposed special treatment (administration of Cyproterone) is the most appropriate form of treatment to promote and maintain Mr UDQ's health and well-being" 'Whether the proposed special treatment is the only or most appropriate way of treating Mr UDQ and is manifestly in his best interests']

Ratio Decidendi

The Tribunal found Mr UDQ incapable of giving consent due to his advanced dementia, accepted evidence that Cyproterone was the only appropriate treatment for his behavioural and prostatic symptoms, confirmed the treatment was manifestly in his best interests, and thus granted consent to the administration of Cyproterone for two years.

Court Disposition

Consent to administration of Cyproterone (Androcur) up to 100 mg daily for two years granted

Orders

  • ['Consent to administration of Cyproterone up to 100 mg daily for two years from the date of order']